John R Heard

5PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 27, 2026
Life expectancy estimation in older men using the prostate cancer comorbidity index in VA & SEER-Medicare cohorts.

|Mar 18, 2026
Alternate-day administration of intravesical gemcitabine and docetaxel to improve clinic utilisation.

John R Heard, Michael Ahdoot

|Feb 14, 2025
Prostate-Specific Antigen Density to Select Magnetic Resonance Imaging-Targeted vs Combined Biopsy for Prostate Cancer Diagnosis: A Secondary Analysis of the Trio Study.

Michael Ahdoot, Aurash Naser-Tavakolian, John R Heard

|Jun 24, 2022
Definitive treatment choice among Black immigrants with prostate cancer: Analysis of patient surveys distributed at a single safety-net institution.

John R Heard, Aaron J Huang, Laura Werle

|Mar 05, 2022
Focal prostate cancer therapy in the era of multiparametric MRI: a review of options and outcomes.

John R Heard, Aurash Naser-Tavakolian, Michael Nazmifar

Pageof 1

Frequent Collaborators

2 joint publications

Michael Ahdoot

1 joint publications

Michael Luu

1 joint publications

Aaron J Huang

1 joint publications

Samhita Mallavarapu